Early Experiences with Intrathecal Administration of Amphotericin B Liposomal Formulation at a Neurosurgical Center

被引:0
|
作者
Michael D. Nailor
Kellie J. Goodlet
Omar Gonzalez
J. Tyler Haller
机构
[1] St. Joseph’s Hospital and Medical Center,Department of Pharmacy Services
[2] Midwestern University College of Pharmacy,Department of Pharmacy Practice
[3] Arizona Pulmonary Specialists,Infectious Disease Division
[4] Barrow Neurological Institute,undefined
[5] St. Joseph Hospital and Medical Center,undefined
来源
CNS Drugs | 2024年 / 38卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:225 / 229
页数:4
相关论文
共 50 条
  • [11] Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study
    Tashiro, Masato
    Takazono, Takahiro
    Ota, Yuki
    Wakamura, Tomotaro
    Takahashi, Akinori
    Sato, Kumiko
    Miyazaki, Taiga
    Obata, Yoko
    Nishino, Tomoya
    Izumikawa, Koichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (10) : 1471 - 1476
  • [12] USE OF A HYPERBARIC SOLUTION FOR ADMINISTRATION OF INTRATHECAL AMPHOTERICIN-B
    ALAZRAKI, NP
    FIERER, J
    HALPERN, SE
    BECKER, RW
    NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (12): : 641 - 646
  • [13] Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma
    Takeda, Takayuki
    Itano, Hideki
    Kakehashi, Ryouhei
    Fukita, Shinichi
    Saitoh, Masahiko
    Takeda, Sorou
    RESPIRATORY MEDICINE CASE REPORTS, 2014, 11 : 7 - 11
  • [15] Amphotericin B liposomal formulation: applicable preparation methods, challenges, and tips
    Seify, Rogayeh
    Zahednezhad, Fahimeh
    Zakeri-Milani, Parvin
    Valizadeh, Hadi
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023, 49 (05) : 367 - 376
  • [16] Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox
    Peruzzu, Daniela
    Fecchi, Katia
    Venturi, Giulietta
    Gagliardi, Maria Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [17] Liposomal amphotericin B formulation and its pharmacokinetics in the treatment of fungal infections
    Griese, M
    MONATSSCHRIFT KINDERHEILKUNDE, 1997, 145 (03) : 269 - 276
  • [18] PHARMACOLOGY AND TOXICOLOGY OF A LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN RODENTS
    PROFFITT, RT
    SATORIUS, A
    CHIANG, SM
    SULLIVAN, L
    ADLERMOORE, JP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 49 - 61
  • [19] PEGylated liposomal formulation of amphotericin B for improved treatment of cutaneous lesihmaniasis
    Ramos, Guilherme Santos
    Carregal, Virginia Mendes
    Marques Borges, Gabriel Silva
    Fujiwara, Ricardo Toshio
    Miranda Ferreira, Lucas Antonio
    Goulart Guimaraes, Pedro Pires
    Georges Frezard, Frederic Jean
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1341 - 1341
  • [20] Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
    Jaafari, Mahmoud Reza
    Hatamipour, Mahdi
    Alavizadeh, Seyedeh Hoda
    Abbasi, Azam
    Saberi, Zahra
    Rafati, Sima
    Taslimi, Yasaman
    Mohammadi, Akram Miramin
    Khamesipour, Ali
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 11 : 156 - 165